Chs Pharma Inc.

Get Full Access

Description

  • CHS Pharma Inc. on Feb. 2013 acquired its Intellectual Property Portfolio from Florida Atlantic University and Hospital for Special Surgery. The IP portfolio is considered a platform technology and currently consists of 4 issued patents, 2 allowed, and 8 applications pending. The mentioned portfolio covers drug candidates for treatments of Actinic Keratosis (Basal and Squamous cell Carcinomas in EU patent), Dry Macular Degeneration, Myocardial Infarction, and Ischemic Stroke. CHS's corporate development strategy is to develop the drug candidates up to Phase II clinical studies and at that point in time either form a strategic partnership or license the technology to other pharmaceutical companies.
  • location

    Headquarters: , , , United States

    More
  • Chs Pharma Inc. phone

    Phone Number:

  • Chs Pharma Inc. website

    Website:

  • Chs Pharma Inc. employees

    Employees:2

  • Chs Pharma Inc. revenue

    Revenue:$1 - 10M

  • Chs Pharma Inc. legal name

    Legal Name:Chs Pharma Inc.

  • Chs Pharma Inc.'s Social Media

    Chs Pharma Inc. linkedin
  • done Is this data correct?
  • |  NAICS Code: 541713  |

    Show More
Person level website identification

for Chs Pharma Inc.

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Frequently Asked Questions regarding Chs Pharma Inc.

  • What is Chs Pharma Inc.'s Revenue?

    Chs Pharma Inc.'s revenue is $1 - 10M

  • What is Chs Pharma Inc.'s NAICS code?

    Chs Pharma Inc.'s NAICS code is 541713

  • How many employees are working in Chs Pharma Inc.

    Chs Pharma Inc. has 2 employees

  • What is Chs Pharma Inc.'s Industry?

    Chs Pharma Inc. is in the industry of Biotechnology

Company Directory